SeaStar Medical raises $3.3M via warrant exercise offering
What's the deal? SeaStar Medical Holding CorporationDealroom has a profile for this one. Try Dealroom → closed a warrant exercise offering that generated roughly $3.3 million in gross proceeds, the company disclosed in an October 5, 2026 Form 8-K filing with the Securities and Exchange CommissionDealroom has a profile for this one. Try Dealroom →.
How it works: Holders of existing common stock purchase warrants exercised them for 854,002 shares at a reduced price of $3.866 each. In return, they received new Series A and Series B Warrants, each exercisable for up to 854,002 shares at $3.616.
The fine print: Series A Warrants carry a five-year term; Series B Warrants run 18 months. Both start from the effective date of a resale registration statement SeaStar has committed to filing within 30 days of October 2, 2026.
What's the money for? The company plans to apply net proceeds to general corporate needs, including potential working capital and capital expenditures.
Who ran it? H.C. Wainwright & Co.Dealroom has a profile for this one. Try Dealroom → acted as exclusive placement agent. It earned a 7.0% cash fee plus a 1.0% management fee, $75,000 in non-accountable expenses, a $15,950 clearing fee, and warrants to buy up to 59,780 shares at $4.8325 each.
The signal: For a small-cap medical company, repricing existing warrants to pull in fresh cash is a familiar tool when conventional raises are tight. The structure trades a discount today for diluted upside later — a bet that near-term capital matters more than the cost of issuing new paper.
Read more: kalkinemedia.com
Image credit: Kitmondo.com
